Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Keith

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|August 4, 2022
Loss of Frizzled 9 in Lung Cells Alters Epithelial Phenotype and Promotes Premalignant Lesion DevelopmentKayla Sompel, Lori D Dwyer-Nield, Alex J Smith, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 27, 2018
Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer ChemopreventionMelissa L New, Collin M White, Polly McGonigle, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 17, 2011
N-nitroso-tris-chloroethylurea induces premalignant squamous dysplasia in miceTyler M Hudish, Laura I Opincariu, Anthony B Mozer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 31, 2017
The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma ModelLori Dwyer-Nield, Gregory A Hickey, Micah Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancerDaniel T Merrick, John Kittelson, Ralph Winterhalder, et al.
Anticancer Research|August 5, 2006
Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesisRobert L Keith, Mark W Geraci, S Patrick Nana-Sinkam, et al.
Carcinogenesis|March 23, 2004
Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2Amy M Meyer, Lori D Dwyer-Nield, Gregory J Hurteau, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 17, 2019
A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former SmokersRobert L Keith, Patrick J Blatchford, Daniel T Merrick, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1Meredith A Tennis, Michelle Van Scoyk, Lynn E Heasley, et al.
Cancer Research|February 7, 2002
Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancerRobert L Keith, York E Miller, Yasushi Hoshikawa, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|August 4, 2022
Loss of Frizzled 9 in Lung Cells Alters Epithelial Phenotype and Promotes Premalignant Lesion DevelopmentKayla Sompel, Lori D Dwyer-Nield, Alex J Smith, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 27, 2018
Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer ChemopreventionMelissa L New, Collin M White, Polly McGonigle, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 17, 2011
N-nitroso-tris-chloroethylurea induces premalignant squamous dysplasia in miceTyler M Hudish, Laura I Opincariu, Anthony B Mozer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 31, 2017
The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma ModelLori Dwyer-Nield, Gregory A Hickey, Micah Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancerDaniel T Merrick, John Kittelson, Ralph Winterhalder, et al.
Anticancer Research|August 5, 2006
Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesisRobert L Keith, Mark W Geraci, S Patrick Nana-Sinkam, et al.
Carcinogenesis|March 23, 2004
Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2Amy M Meyer, Lori D Dwyer-Nield, Gregory J Hurteau, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 17, 2019
A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former SmokersRobert L Keith, Patrick J Blatchford, Daniel T Merrick, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1Meredith A Tennis, Michelle Van Scoyk, Lynn E Heasley, et al.
Cancer Research|February 7, 2002
Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancerRobert L Keith, York E Miller, Yasushi Hoshikawa, et al.
Pageof 6